ArticleFrontiers in endocrinology2026

Osteoactivin/GPNMB as a candidate biomarker of diabetic nephropathy in type 2 diabetes: associations with angiogenic and kidney injury biomarkers.

Mohamed Abu-Farha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.